Characteristics of Apixaban-Treated Patients, Evaluation of the Dose Prescribed, and the Persistence of Treatment: A Cohort Study in Catalonia

Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure

(2018) Gianluigi Savarese et al.   HEART

Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users

(2018) Colleen A. McHorney et al.   PLoS One

Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation

(2017) Beenish S. Manzoor et al.   PHARMACOTHERAPY

Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice

(2017) Steve Deitelzweig et al.   THROMBOSIS AND HAEMOSTASIS

Adherence to oral anticoagulant therapy in patients with atrial fibrillation

(2017) Roberto Cangemi et al.   THROMBOSIS AND HAEMOSTASIS

A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation

(2016) Kehinde O. Obamiro et al.   American Journal of Cardiovascular Drugs

Prevalence of drug-related problems associated with direct oral anticoagulants in hospitalized patients: a multicenter, cross-sectional study

(2016) M. Viprey et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Early real-world evidence of persistence on oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a cohort study in UK primary care

(2016) Michelle E Johnson et al.   BMJ Open

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation

(2016) Xiaoxi Yao et al.   Journal of the American Heart Association

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation

(2016) Xiaoxi Yao et al.   Journal of the American Heart Association

Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation

(2015) Tomas Forslund et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Patterns of Initiation of Oral Anticoagulants in Patients with Atrial Fibrillation— Quality and Cost Implications

(2014) Nihar R. Desai et al.   AMERICAN JOURNAL OF MEDICINE

Development of apixaban: a novel anticoagulant for prevention of stroke in patients with atrial fibrillation

(2014) Michael S. Hanna et al.   Annals of the New York Academy of Sciences

Evaluation of the effect of naproxen on the pharmacokinetics and pharmacodynamics of apixaban

(2014) Charles Frost et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Atrial fibrillation guidelines across the Atlantic: a comparison of the current recommendations of the European Society of Cardiology/European Heart Rhythm Association/European Association of Cardiothoracic Surgeons, the American College of Cardiology Foundation/American Heart Association/Heart Rhythm Society, and the Canadian Cardiovascular Society

(2013) Paulus Kirchhof et al.   EUROPEAN HEART JOURNAL

Dabigatran and rivaroxaban prescription for atrial fibrillation in Catalonia, Spain: the need to manage the introduction of new drugs

(2013) Amelia Troncoso et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPEAN HEART JOURNAL

Drug and dietary interactions of warfarin and novel oral anticoagulants: an update

(2011) Edith Nutescu et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Apixaban in Patients with Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Is bigger better? An argument for very low starting doses

(2010) J. P. McCormack et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome

(2009)   CIRCULATION